# McLaren Health Care account plan

> McLaren Health Care is a Flint-based nonprofit Michigan health system with 12 hospitals, 3,100 licensed beds and health plans: $6.95 billion FY2025 revenue.

## At a glance

McLaren Health Care Corporation is a Flint, Michigan-based not-for-profit integrated health system: eleven regional McLaren hospitals plus Karmanos Cancer Center, ambulatory campuses, the McLaren Medical Group physician practice, an ACO and health plans in Michigan (McLaren Health Plan) and Indiana (MDwise). It has 3,100 licensed beds and in 2025 recorded 85,925 discharges, 398,705 ER visits and 3,718,068 ambulatory visits. FY2025 (year to September 30, 2025) total unrestricted revenue was $6,947,557K, of which patient service revenue $3,561,083K and premium revenue $2,958,629K; operating income more than doubled to $181,200K. Annual payroll is $1.91 billion. It is led by President and CEO Philip A. Incarnati.

## Business units

- **Provider services (hospitals and physicians)** (about 51% of FY2025 revenue ($3,561,083K patient service revenue)): Eleven McLaren regional hospitals (including Flint, Bay Region, Greater Lansing, Macomb, Oakland, Northern Michigan and Port Huron) and ambulatory centers across Michigan, paid mainly by Medicare ($1,772,631K) and Blue Cross ($725,783K). Per COO Chad Grant, nearly two-thirds of revenue is outpatient, and the system acquired a medical center in 2025.
- **Karmanos Cancer Institute**: The system's oncology service line, with 17 Michigan locations; new oncology cases grew to 15,754 in FY25. It runs the McLaren Proton Therapy Center and is renewing its NCI comprehensive cancer center designation, led by CEO Dr. Boris Pasche.
- **Insurance (McLaren Health Plan and MDwise)** (about 43% of FY2025 revenue ($2,958,629K premium revenue)): McLaren Health Plan serves Michigan Medicaid with about 240,000 members, and MDwise served Indiana Medicaid with about $1.7 billion of FY2025 premium revenue until Indiana ended the contract on December 31, 2025. The insurance entities ran an operating loss of $14,487K in FY2025.
- **McLaren Medical Group**: The employed physician group, with over 600 providers and over 30 rural health centers; 171 providers started in 2025, and McLaren acquired the primary care group Park Medical Centers.

## Strategic priorities

- **Ambulatory growth**: A $40 million Grand Ledge campus opened in October 2025 and a $53 million ambulatory, orthopedic and emergency center broke ground in Bay City, extending the Clarkston, Fenton, West Branch, Oxford and Cheboygan campus model.
- **Physician group acquisitions**: McLaren offers group practices partnership as an alternative to private equity, acquired Park Medical Centers and plans more such group acquisitions.
- **Service line build-out**: A new Heart & Vascular Institute covering all 12 hospitals plans up to 10 new or upgraded CT scanners, cath lab consolidation toward 80-85% utilization and an ECMO program at Flint.
- **AI in revenue cycle and prior authorization**: SmarterPreBill uncovered $11.3 million in annualized new revenue, two revenue-cycle bots went live in 2025, and McLaren Health Plan wants to automate prior-auth decisions under the new CMS data-sharing rule.
- **NCI renewal at Karmanos**: Karmanos submitted its five-year NCI comprehensive cancer center renewal in January 2026, with an answer expected late 2026 or early 2027.
- **Quality, finances and workforce**: The CEO and Chairman name four priorities: quality and safety, strategic growth of services, financial strength, and a workplace that attracts, retains, respects and rewards employees.

## Investments and deals

- **Capital spending**: Purchases of property and equipment rose to $164,448K in FY2025 from $133,490K, with about $61 million committed to construction and financial and clinical IT projects.
- **Ambulatory campuses**: The $40 million Grand Ledge campus (opened October 2025) and the $53 million Bay City ambulatory, orthopedic and emergency center.
- **Acquisitions**: A medical center acquired in 2025 ($10,818K of goodwill) and the Park Medical Centers primary care group.
- **Digital pathology and cancer expansion**: Digital pathology with Roche rolled out system-wide in July 2025; Karmanos opened Karmanos Dearborn and completed the Karmanos-Flint and Proton Therapy Center expansions in May 2025.

## Challenges and risks

- **Loss of the MDwise Indiana contract**: Indiana ended the MDwise Medicaid contract on December 31, 2025, a year early, removing about $1.7 billion of premium revenue, with about $293 million receivable from the State of Indiana.
- **Federal Medicaid cuts**: Leaders flag the budget bill set to take more than $1.3 trillion away from Medicaid; most premiums come from Michigan and Indiana Medicaid, and the Michigan Hospital Assessment Program needs annual federal approval.
- **Research funding uncertainty**: Karmanos faced the threat to cut NIH/NCI indirect funding and pulled-then-reinstated grants, which Pasche calls a year of stressful events for the academic community.
- **Unknown risk from new plan members**: McLaren Health Plan's top risk is large payers exiting markets and leaving mid-size plans with members of unknown, higher risk.
- **Labor competition and compliance**: Inflation and competition for nurses and technicians weigh on costs, and the single audit gave an adverse compliance opinion on a $1,350,000 grant over procurement procedures.

## What leadership says

> "We don't really view cost containment and member experience as trade offs." — Patrick Stevenson, Vice President, Data and Technology, McLaren Health Plan, Becker's Payer Issues Podcast, May 29, 2026

> "what we see today may not be what we'll we'll see next year" — Boris Pasche, President and CEO, Barbara Ann Karmanos Cancer Institute, Becker's Healthcare Podcast, August 21, 2026

> "navigated a strong and steady path forward in 2025" — Philip A. Incarnati, President and CEO, and Daniel Boge, Chairman, Joint letter in the McLaren Health Care Annual Report 2025


## Where a supplier can help

- **Ambulatory build-out**: The Grand Ledge and Bay City campuses and the stated outpatient growth strategy need imaging, emergency, construction and clinic-operations suppliers.
- **Cardiology equipment**: The Heart & Vascular Institute's plan for up to 10 new or upgraded CT scanners, cath lab consolidation and an ECMO program is a direct equipment and services opportunity.
- **Revenue-cycle and prior-auth automation**: Proven gains from SmarterPreBill and the health plan's goal of automating prior authorization make AI and revenue-cycle vendors relevant to the financial-strength priority.
- **Member risk analytics**: McLaren Health Plan's investment in predictive analytics and segmentation for rising-risk members suits care-management and population-health tools.
- **Offsetting lost premium revenue**: Losing about $1.7 billion of MDwise premiums and Medicaid cut risk put a premium on cost-reduction, procurement and workforce-retention offers.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [McLaren Health Care Corporation and Subsidiaries - Consolidated Financial Report with Additional Information, September 30, 2025 (FY2025 audited statements and single audit)](https://app.fac.gov/dissemination/report/pdf/2025-09-GSAFAC-0000421117)

Annual report · 2026-01-07

- McLaren Health Care Corporation is a Flint-based not-for-profit "major provider of health care services to residents throughout Michigan", with "a significant portion" of revenue from its insurance organizations in Michigan and Indiana (McLaren Health Plan, MDwise); fiscal year ends September 30.
- FY2025 total unrestricted revenue, gains and other support was $6,947,557K (FY2024: $6,658,753K): patient service revenue $3,561,083K, premium revenue $2,958,629K, other $418,419K.
- Operating income more than doubled to $181,200K (FY2024: $82,725K); excess of revenue over expenses was $466,626K after $285,426K of nonoperating income (investment income and unrealized gains).
- Expenses of $6,766,357K are dominated by medical claims ($2,683,198K), salaries and wages ($1,599,383K), purchased services ($1,035,805K) and supplies ($930,536K); by function, provider services cost $2,978,373K and insurance $2,856,290K.
- Balance sheet at 30 Sep 2025: total assets $7,156,873K, cash $809,533K, investments $2,441,052K, long-term debt $1,612,884K net of current portion, net assets $3,794,105K; two undrawn $150,000K credit lines (JPMorgan Chase, PNC Bank).
- Patient revenue by payor: Medicare $1,772,631K, Blue Cross $725,783K, Medicaid $553,700K, commercial and managed care $505,155K.
- Capex (purchase of property and equipment) rose to $164,448K; about $61 million of construction and IT commitments; a medical center was acquired during 2025, adding $10,818K of goodwill.
- Key risk: after year end, Indiana told McLaren it will end the MDwise Medicaid contract on December 31, 2025, a year early; MDwise premium revenue was about $1.7 billion in FY2025 and about $293 million is receivable from the State of Indiana.
- Plante & Moran issued an unmodified opinion on January 7, 2026; the single audit gave an adverse compliance opinion on one $1,350,000 Congressional Directives grant (procurement findings 2025-001 and 2025-002).

### [McLaren Health Care Annual Report 2025 - Advancing Excellence in Care Through Strategic Growth](https://www.mclaren.org/Uploads/Public/Documents/corporate/McLaren_2025_AR_Digital.pdf.pdf)

Report

- McLaren's 2025 Annual Report presents the system as "one of the largest integrated health systems in the state" (Michigan). It reports net revenue of $6.95 billion, annual payroll of $1.91 billion, 3,100 licensed beds and community benefit of $407.1 million.
- 2025 activity: 398,705 ER visits, 85,925 discharges, 760,960 days of inpatient care, 3,718,068 ambulatory visits, 75,452 surgeries, 4,434 births and 93,846 contracted providers.
- The 12 hospitals are 11 McLaren regional hospitals plus Karmanos Cancer Center. Karmanos has 17 Michigan locations and grew oncology new cases to 15,754 in FY25.
- CEO Philip A. Incarnati and Chairman Daniel Boge name four strategic priorities: quality and safety, strategic growth of services, financial strength, and a workplace that "attracts, retains, respects and rewards employees".
- The ambulatory push: a $40 million Grand Ledge campus opened in October 2025, and a $53 million ambulatory, orthopedic and emergency center broke ground in Bay City. Per COO Chad Grant, "nearly two-thirds" of revenue is outpatient.
- Physician strategy: McLaren acquired Park Medical Centers, a large primary care group, and plans "more such group acquisitions". McLaren Medical Group employs over 600 providers, and 171 providers started in 2025.
- Service lines now span oncology, neuroscience, women's health, pathology, emergency and a new Heart & Vascular Institute. Digital pathology (with Roche) rolled out system-wide in July 2025.
- AI in the revenue cycle: SmarterDx's SmarterPreBill "uncovered $11.3 million in annualized new revenue". The revenue-cycle bots Maggie and Dolly were launched in 2025.
- Workforce: nurse vacancy fell from 16.2% (end FY21) to 4.2% (end FY25). The graduate medical education program has more than 600 residents and fellows.
- The leaders flag Medicaid risk from the "Big Beautiful" budget bill, which is set to take "more than $1.3 trillion away from Medicaid". Michigan Medicaid reimbursement is now at the average commercial rate, renewed for 2026.

### [Becker's Healthcare Podcast - Boris Pasche, MD, PhD, FACP, President and CEO of Barbara Ann Karmanos Cancer Institute](https://podcast.show/beckershealthcarepodcast/episode/155070031/)

Podcast · Boris Pasche, President and CEO, Barbara Ann Karmanos Cancer Institute (McLaren Health Care) · 2026-08-21

- Dr. Boris Pasche has been president and CEO of the Barbara Ann Karmanos Cancer Institute (McLaren's cancer service line) since 2023. He also chairs oncology at Wayne State University.
- The 2026 priority was Karmanos' five-year NCI comprehensive cancer center renewal: the application went in in January, reviews came in May and the site visit has taken place, with an answer expected "later this year and early next year".
- Headwinds came from the new administration: the threat to cut NIH/NCI indirect funding, and DEI-related grants that were pulled and then reinstated. Pasche now sees bipartisan congressional support for cancer research.
- On growth: new therapies (KRAS inhibitors in pancreatic cancer, theranostics, CAR T cells) can displace surgery or radiation, so centers must offer new therapies quickly across their catchment area.
- Karmanos serves "about 17 sites throughout Michigan". Advanced therapies such as proton therapy and theranostics stay at large referral centers and reach rural patients through referral, transport and remote consultation.

### [Becker's Payer Issues Podcast - Using Data and AI to Drive Proactive Member Care (McLaren Health Plan)](https://podcast.show/beckerspayerissuespodcast/episode/153917383/)

Podcast · Patrick Stevenson, Vice President, Data and Technology, McLaren Health Plan · 2026-05-29

- Patrick Stevenson, VP of data and technology at McLaren Health Plan, the Medicaid plan "primarily owned by" McLaren Health Care, spoke on Becker's Payer Issues Podcast (recorded live at the fourth annual spring payer issues roundtable).
- The plan serves "240,000 members in the Flint, Michigan area", mostly Medicaid. His role is to help "scale" the organization.
- His top risk: large payers entering and exiting markets and leaving mid-size plans with members of unknown, "disproportionate" risk. McLaren's response is to identify and underwrite new members' risk quickly.
- On cost containment versus member experience: "They're really improved together": predictive analytics and segmentation target high-risk and especially rising-risk members through care management, primary care alignment and targeted outreach.
- AI priority: use the new CMS prior authorization data-sharing rule ("double o five seven f") to automate prior-auth decisions, and drop prior auth where approval is near-automatic ("95% of the time").
- AI for member interactions starts with low-risk uses and expands as members, staff and the tools mature.

## Questions about McLaren Health Care

### What is McLaren Health Care?

A Flint-based not-for-profit integrated health system in Michigan with 12 hospitals including Karmanos Cancer Center, ambulatory centers, an employed physician group and Medicaid health plans.

### What is McLaren Health Care's revenue?

FY2025 (year to September 30, 2025) total unrestricted revenue was $6,947,557K, with operating income of $181,200K.

### How big is McLaren's workforce and capacity?

It has 3,100 licensed beds, an annual payroll of $1.91 billion and over 600 providers in McLaren Medical Group.

### What are McLaren's strategic priorities?

Quality and safety, strategic growth of services such as ambulatory campuses and service lines, financial strength, and attracting and retaining employees.

### Who leads McLaren Health Care?

Philip A. Incarnati is President and CEO and Daniel Boge is Board Chairman; Dr. Boris Pasche leads Karmanos Cancer Institute.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
